Dermata Therapeutics Inc.
DRMA
All references in this report to Dermata, the Company, we, us, or our mean Dermata Therapeutics, Inc. unless stated otherwise or the context otherwise indicates. Overview We are a scientific leader in skincare, dedicated to the development and commercialization of products that address common and underserved skin conditions.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$9M
▲ +38.5% YoY
Op. Margin
–
ROIC
-153.01%
▲ +92.0pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$9M
▲ +30.5% YoY
Net Debt
-$5M
Net Cash Position
Cash & Equiv.
$5M
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with DRMA
Dermata Therapeutics (DRMA) in two numbers
Questions about Dermata Therapeutics
Does Dermata Therapeutics (DRMA) pay a dividend?
No. Dermata Therapeutics (DRMA) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 9 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in DRMA's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing DRMA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.